Policies on this page
Palmetto GBA (continued) 187 policies · 18 states
Show 9 other Palmetto GBA policies on this page (pages not in search results)
- L40046 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40058 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40187 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40189 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40210 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40238 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40257 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40263 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40328 Allergy Diagnostic Testing
Wellpoint Federal 88 policies · 25 states
- L33394 Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
- L33627 Non-Invasive Vascular Studies
- L35936 Facet Joint Interventions for Pain Management
- L35000 Molecular Pathology Procedures
- L39036 Epidural Steroid Injections for Pain Management
- L33393 Hospice - Determining Terminal Status
- L33577 Transthoracic Echocardiography (TTE)
- L33631 Outpatient Physical and Occupational Therapy Services
- L33632 Psychiatry and Psychology Services
- L33557 Cardiac Catheterization and Coronary Angiography
- L33569 Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
- L33622 Pain Management - Injection of tendon sheaths, ligaments, bursa, and ganglion cysts
- L33636 Routine Foot Care and Debridement of Nails
- L33558 Cataract Extraction
- L33563 Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory Structures
- L40048 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L33396 Posterior Tibial Nerve Stimulation for Voiding Dysfunction
- L33399 EEG – Ambulatory Monitoring
- L33559 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33560 Cardiovascular Nuclear Medicine
- L33567 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L33574 Visual Fields Testing
- L33575 Varicose Veins of the Lower Extremity, Treatment of
- L33576 Urodynamics
- L33578 Transrectal Ultrasound
- L33585 Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography
- L33614 Debridement Services
- L33616 Osteopathic Manipulative Treatment
- L33619 Nonvascular Extremity Ultrasound
- L33621 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L33623 Percutaneous Coronary Intervention
- L33624 Psychiatric Inpatient Hospitalization
- L33626 Psychiatric Partial Hospitalization Programs
- L35001 Reduction Mammaplasty
- L35028 Venous Angioplasty with or without Stent Placement for the Treatment of Chronic Cerebrospinal Venous Insufficiency
- L35074 Heavy Metal Testing
- L35075 Proton Beam Therapy
- L35076 Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
- L36406 Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint
- L37606 Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases
- L37810 Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
- L38371 Multimarker Serum Tests Related to Ovarian Cancer Testing
- L39297 Off-label Use of Rituximab and Rituximab Biosimilars
- L39314 Off-Label Use of Intravenous Immune Globulin (IVIG)
- L39513 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin
- L39995 Pharmacogenomic Testing
- L40302 Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
Show 41 other Wellpoint Federal policies on this page (pages not in search results)
- L33398 Transcranial Magnetic Stimulation
- L33573 B-type Natriuretic Peptide (BNP) Testing
- L33579 Transesophageal Echocardiography (TEE)
- L33580 Speech-Language Pathology
- L33591 RAST Type Tests
- L33628 Panretinal (Scatter) Laser Photocoagulation
- L33630 Corneal Pachymetry
- L33633 Magnetic Resonance Angiography (MRA)
- L34380 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L35080 Select Minimally Invasive GERD Procedures
- L35098 Nerve Conduction Studies and Electromyography
- L36039 Total Joint Arthroplasty
- L36236 Autonomic Function Testing
- L36831 Visual Electrophysiology Testing
- L37244 Micro-Invasive Glaucoma Surgery (MIGS)
- L37475 Frequency of Hemodialysis
- L37535 Vitamin D Assay Testing
- L38014 Corneal Hysteresis
- L38367 Fluid Jet System Treatment for LUTS/BPH
- L38387 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38571 Colon Capsule Endoscopy (CCE)
- L38623 Implantable Continuous Glucose Monitors (I-CGM)
- L38667 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38937 Platelet Rich Plasma
- L38968 Thyroid Nodule Molecular Testing
- L39027 Respiratory Pathogen Panel Testing
- L39075 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L39139 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39189 Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG)
- L39226 Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)
- L39455 Sacroiliac Joint Injections and Procedures
- L39611 Urine Drug Testing
- L39662 Trigger Point Injections (TPI)
- L39726 KidneyIntelX and KidneyIntelX.dkd Testing
- L39770 Cervical Fusion
- L39832 Botulinum Toxin Injections
- L39863 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L40168 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40267 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40330 Allergy Diagnostic Testing
- L40334 Erythropoiesis Stimulating Agents
Wisconsin Physicians Service Insurance Corporation 110 policies · 48 states · continues on the next page
- L37228 Wound Care
- L38841 Facet Joint Interventions for Pain Management
- L34596 Immunizations
- L34614 Colonoscopy and Sigmoidoscopy-Diagnostic
- L34645 Urine Drug Testing
- L35498 Removal of Benign Skin Lesions
- L35751 Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
- L35755 Non-Invasive Abdominal / Visceral Vascular Studies
- L36839 Polysomnography and Other Sleep Studies
- L39051 Cosmetic and Reconstructive Surgery
- L39054 Epidural Steroid Injections for Pain Management
- L34526 Surgical Treatment of Obstructive Sleep Apnea (OSA)
- L34528 Blepharoplasty, Blepharoptosis and Brow Lift
- L34536 Treatment of Varicose Veins of the Lower Extremities
- L34594 Nerve Conduction Studies and Electromyography
- L34615 Visual Fields
- L34623 Intraoperative Neurophysiological Testing
- L34624 Somatosensory Testing
- L34636 Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring)
- L34641 Transcranial Magnetic Stimulation (TMS)
- L34646 Psychological and Neuropsychological Testing
- L34648 Bisphosphonate Drug Therapy
- L34658 Vitamin D Assay Testing
- L34659 Endoscopic Treatment of GERD
- L34761 Percutaneous Coronary Interventions
- L34771 Immune Globulins
- L35121 Coronary Computed Tomography Angiography (CCTA)
- L35124 Autonomic Function Testing
- L35486 Pelvic Floor Dysfunction: Anorectal Manometry and EMG
- L35490 Category III Codes
- L35753 Non-Invasive Cerebrovascular Studies
- L35761 Non-Invasive Peripheral Arterial Vascular Studies
- L35998 Non-Coronary Vascular Stents
- L36000 Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain
- L36523 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36797 MolDX: NRAS Genetic Testing
- L36805 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L36811 MolDX: Breast Cancer Assay: Prosigna®
- L37003 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L37015 Visual Electrophysiology Testing
- L37537 Frequency of Hemodialysis
- L38435 MolDX: Pharmacogenomics Testing
- L38441 MolDX: Blood Product Molecular Antigen Typing
- L38528 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38678 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38682 Transurethral Waterjet Ablation of the Prostate
- L38684 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38686 Implantable Continuous Glucose Monitors (I-CGM)
- L38839 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L39040 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L39042 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L39044 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39475 Sacroiliac Joint Injections and Procedures
- L39477 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39481 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39529 Intraarticular Knee Injections of Hyaluronan
- L39624 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39709 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39711 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39720 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
How the list is ordered
Each active policy appears once, under the first Medicare Administrative Contractor hub that lists it, in the order of the contractor hubs; policies that no A/B contractor hub lists, which are the durable medical equipment, home health and hospice policies, close the list. Inside a contractor, the policies with a full reference page come first, ordered by how often people search for the policy number, and the contractor's other policies follow as text in policy-number order. A contractor whose policies run across a page break is marked as continued, and the contractor hub always lists every active policy in that jurisdiction on one page.
Reading a local coverage policy
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so start from the contractor for the state where the service is furnished, or from the durable medical equipment contractor region for supplies and equipment. Then check the date of service against the policy's revision date: a revision that adds or removes diagnosis codes changes which claims pass the edit from that date forward.
The policy text sets out the covered indications, limitations and documentation requirements. Since January 2019 the procedure and diagnosis codes have lived in a companion billing and coding article, which is what the contractor loads as the claims edit; each policy page here shows the article's covered-code count with a sample and opens the full covered and non-covered lists. A policy listed as text on this page still has its own page with the same data; it is kept out of search results because it is another contractor's version of a title that its topic comparison covers, or a short policy with little search demand.
Other ways to find a policy
The LCD code lookup answers the question for one procedure code, one state and one diagnosis. The LCD lookup guide explains contractor jurisdictions and the appeal path, the NCD guide explains when a national policy overrides a local one, and the LCD coverage variation report shows how far the versions of a shared title differ between contractors. The topic list on the hub links every title that several contractors publish.
For teams evaluating QuickIntell software
Where QuickIntell fits with this policy
If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. This continuation page is kept out of search results; the LCD hub and each policy's own page are the pages meant to be found. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.